Acadian Asset Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Acadian Asset Management’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-126,978	Closed	-$1.36M	–	1963
2022 Q3	$1.36M	Hold	126,978	–	–	0.01%	724
2022 Q2	$1.52M	Buy	126,978 +10,500	+9%	+$169K	0.01%	703
2022 Q1	$2.49M	Buy	116,478 +44,562	+62%	+$1.18M	0.01%	618
2021 Q4	$2.42M	Buy	71,916 +7,475	+12%	+$208K	0.01%	612
2021 Q3	$1.66M	Buy	64,441 +8,015	+14%	+$143K	0.01%	726
2021 Q2	$755K	Sell	56,426 -3,405	-6%	-$42.1K	﹤0.01%	1011
2021 Q1	$635K	Sell	59,831 -1,009	-2%	-$11.5K	﹤0.01%	1109
2020 Q4	$489K	Sell	60,840 -1,208	-2%	-$9.51K	﹤0.01%	1239
2020 Q3	$464K	Buy	62,048 +29,527	+91%	+$262K	﹤0.01%	1154
2020 Q2	$293K	Buy	32,521 +24,393	+300%	+$253K	﹤0.01%	1366
2020 Q1	$79K	Buy	8,128 +6,622	+440%	+$79.3K	﹤0.01%	1401
2019 Q4	$21K	Buy	+1,506	New	+$22K	﹤0.01%	1720
2018 Q4	–	Sell	-2,470	Closed	-$44K	–	1875
2018 Q3	$44K	Sell	2,470 -3,948	-62%	-$68.4K	﹤0.01%	1396
2018 Q2	$92K	Sell	6,418 -3,699	-37%	-$65K	﹤0.01%	1261
2018 Q1	$194K	Buy	10,117 +2,540	+34%	+$54.9K	﹤0.01%	1068
2017 Q4	$174K	Buy	+7,577	New	+$243K	﹤0.01%	985

Other funds holding OPNT

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NYLIM

New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return

Acadian Asset Management's OPNT Position: Q4 2022 in Review

Acadian Asset Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q4 2022, closing a stake of 126,978 shares — an estimated $1.36M sold.

Acadian Asset Management first reported a position in OPNT in Q4 2017 and held it in 16 quarters. The position peaked at $2.49M in Q1 2022. 37 funds tracked by Wall St. Rank hold OPNT as of Q4 2022.

Acadian Asset Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Acadian Asset Management sold 126,978 Opiant Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $1.36M.
Acadian Asset Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 16 quarters.
Acadian Asset Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $2.49M in Q1 2022.
37 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Acadian Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.